Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells

INTRODUCTION: Current clinical strategies for treating hormonal breast cancer involve the use of anti-estrogens that block estrogen receptor (ER)α functions and aromatase inhibitors that decrease local and systemic estrogen production. Both of these strategies improve outcomes for ERα-positive breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Binoj C, Vallabhaneni, Sreeram, Tekmal, Rajeshwar R, Vadlamudi, Ratna K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218960/
https://www.ncbi.nlm.nih.gov/pubmed/21834972
http://dx.doi.org/10.1186/bcr2929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218960/
https://www.ncbi.nlm.nih.gov/pubmed/21834972
http://dx.doi.org/10.1186/bcr2929

Ejemplares similares